Associate Professor of Neurobiology, Harvard Medical School
Judith Steen investigates the molecular features of tau in patients with Alzheimer’s disease. Her research suggests that biomarkers in the early stages of disease are very different than later stages, a finding that has implications for stage-specific therapeutics and the pathways associated with the treatments.
